Navigation Links
Samaritan Partners 'Forgetful' Rat Model to Taconic to Commercialize
Date:10/1/2008

The Samaritan Alzheimer's Rat Model

- Mimics Human Alzheimer's

- Speeds 'Race for Time' to Find Cure

- Saves Valuable Research Money

LAS VEGAS, Oct. 1 /PRNewswire-FirstCall/ -- Samaritan Pharmaceuticals (OTC Bulletin Board: SPHC) (http://www.samaritanpharma.com) and Taconic Farms, Hudson, New York, are pleased to announce they have inked a worldwide partnering agreement to commercialize "The Samaritan Alzheimer's Rat Model." The "forgetful" rat model is a research tool used by scientists to study the effectiveness of their new drugs to treat Alzheimer's disease. The unique benefits of the rat model lie in its ability,

-- To mimic many features of human Alzheimer's including memory loss,

-- Speed a scientist's "race for time" in finding a cure for the

mind-robbing disease

-- Save scientists valuable research money.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081001/LAW054)

The rat model is now available exclusively through Taconic. Samaritan will receive royalties on net sales. Financial terms were not disclosed.

"Taconic is extremely pleased to offer researchers a new and potentially invaluable weapon in the war on neurodegenerative disease," said Todd Little, President of Taconic. "The rapid time to disease state of the Samaritan Alzheimer's Rat Model will enable investigators to conduct Alzheimer's drug target screening on a much faster timeline than ever before."

The rat model is published in Pharmacology, 2006;76:19-33

"Taconic provides us with an experienced partner to monetize this unique animal model to 'rat out' Alzheimer's. The rat model is groundbreaking, in that it offers significant advantages over other options previously available for the s
'/>"/>

SOURCE Samaritan Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
2. Riverside Partners Sells MicroCal to GE Healthcare
3. onTargetjobs and ClearedConnections Announce Online Recruitment Partnership
4. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
5. Satyam Partners with Oracle to Provide Clinical Development Applications
6. alli(TM) Partners with Breast Cancer Network of Strength(TM) to Support Women Challenged by Breast Cancer, Weight Loss or Both
7. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
8. Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options
9. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
10. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
11. NIST and partners identify tiny gold clusters as top-notch catalysts

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... Novavax, Inc. (Nasdaq: ...d today that the company will be presenting at the...er 2, 2009 at 12:30 pm local time at The New York ...w of the company,s business strategy, research and...link to the live audio only presentation can be ac...
(Date:11/30/2009)...ire/ -- Dr. Jessica Torrente, Assistant Professor ...al Center in Washington, D.C., demonstrated the in... (BSGI) in clinical practice as an adjunct imaging... at the annual meeting of the Radiological Society...e exhibit was to demonstrate how BSGI is used in t...
(Date:11/30/2009)...PRNewswire-FirstCall/ -- BioMarin Pharmaceutical I... and Drug Administration (FDA) has granted orphan ..., amifampridine phosphate, for the rare autoimmune... 3,4-DAP has previously received orphan drug desi...mmittee for Medicinal Products for Human Use of th...
(Date:11/30/2009)... Nov. 30 Exiqon A/S (NASDAQ OMX Co...Medical School ICCB-Longwood Screening Facility (I... Center of Excellence. ICCB-L supports investigat...itals and institutions, for high-throughput screen...croRNAs are a novel class of small, non-coding RNA...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3
...e Will be Core Application for Multi- Faceted...ASHINGTON, Nov. 5 Netsmart Technologies, Inc., a,...ervices for health and,human services organization...mplement its public health software and provide re... and Wellness Promotion (DHWP). The,announcement w...
...287 show clinical benefit, BOULDER, Colo., Nov. 5...announced today financial results for,the third qu...the third quarter of 2007 was $6.1 million, or $0....third quarter of 2006 of,$3.6 million, or $0.22 pe...arter of 2007 and 2006 is non-cash equity compensa...
...understanding the atomic forces that cause frictio...hers from the University of Pennsylvania, the Univ...y,s Argonne National Laboratory. , The research, ...vania, found a significant difference in friction ... with different isotopes of hydrogen and then rubb...
Other Biology Technology:Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software 2Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 2Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 3Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 4Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 5Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 6Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 7Heavier hydrogen on the atomic scale reduces friction 2
(Date:11/25/2009)...ptember 11, firefighters, police officers and ambu...the World Trade Center complex. They battled to sa...d for survivors, tackled fires and evacuated as ma... an estimated 17,000 people. And making their jobs...s: frightened workers and their relatives jammed m...
(Date:11/25/2009)...the course of a lifetime, the heart pumps some 250...order to do this, the muscle fibers of the heart h...aded by Dr. Wolfgang Rottbauer, vice chair of the ...y Hospital (Chairman: Prof. Dr. H. A. Katus), has ...tability of the smallest muscular unit, the sarcom...
(Date:11/24/2009)...housands of years it has been prescribed by tradit...ts from headaches and stomach pain to fever and fl...stle University have been able to scientifically p...ata otherwise known as Brazilian mint. , Testin...am led by researcher Graciela Rocha was able to sh...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3New genetic cause of cardiac failure discovered 2Got a pain? -- Have a cup of Brazilian mint 2Pamela Lyon M D Achieves Board Certification in Bariatric Weight Loss Medicine 48400 1Pamela Lyon M D Achieves Board Certification in Bariatric Weight Loss Medicine 48400 2New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives 12549 1New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives 12549 2New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives 12549 3New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives 12549 4New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives 12549 5New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives 12549 6Naps with rapid eye movement sleep increase receptiveness to positive emotion 48396 1Naps with rapid eye movement sleep increase receptiveness to positive emotion 48396 2
... chemotherapy with short-term structural changes i... study. Published in the January 1, 2007 issue of ...newsroom ), a peer-reviewed journal of the America... months of receiving adjuvant chemotherapy, signif... analysis and other cognitive functions were signi...
... When something has your full attention you see it... liable to miss something important. Now a new Nor...ntion operates. , The mystery of how attention imp...on has been a long-time concern of scientists. One... produce stronger brain activity, as if the stimul...
...e Kimmel Cancer Center at Thomas Jefferson Univers... involved in regulating aging also blocks prostate...l Cancer Center director Richard Pestell, M.D., Ph...etter understanding the development of prostate ca... SIRT1 is a member of a family of enzymes called s...
Other Biology News:Chemotherapy temporarily affects the structures of the human brain 2Paying attention sets off symphony of cell synchronization 2Jefferson scientists find aging gene also protects against prostate cancer development 2
Mouse Anti-Plastin L Monoclonal Antibody, Unconjugated, Clone LPL4A.1 from Abcam
Mouse Anti-Chloramphenicol Acetyltransferase Monoclonal Antibody, Unconjugated, Clone CAT-1 from Abcam
...mpetent Yeast Cells are designed for use with the ...ae strain MaV203 contains deletions in the endogen...wo-hybrid systems. The strain also has leu2 and tr...ey vectors. MaV203 contains three GAL4 inducible r...
mCD-1 Multi-Probe Template Set from BD Biosciences Pharmingen
Biology Products: